SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer
Pengcheng Yu(Zhejiang Chinese Medical University), Zhiyuan Xu(Chinese Academy of Sciences)
Cited by 9
Related Papers
Clinicopathological Characteristics and Prognosis of Signet Ring Gastric Cancer: A Population-Based Study
|Frontiers in Oncology|2021|18
Abstract 1305: Cellular and molecular landscape of metastatic gastric cancer
|Cancer Research|2023|0